WPC
TLSI icon

White Pine Capital’s TriSalus Life Sciences TLSI Stock Holding History

White Pine Capital’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49M Buy
547,577
+347,732
+174% +$1.38M 0.59% 48
2026
Q1 		$799K Buy
199,845
+141,294
+241% +$692K 0.22% 124
2025
Q4 		$409K Sell
58,551
-1,182
-2% -$6.62K 0.11% 172
2025
Q3 		$278K Buy
+59,733
New +$280K 0.08% 206

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

White Pine Capital's TLSI Position: Q2 2026 in Review

White Pine Capital increased its TriSalus Life Sciences (TLSI) stake by 174% in Q2 2026, buying an estimated $1.38M and bringing the position to 547,577 shares worth $2.49M. The position accounts for 0.59% of the portfolio, ranked #48.

White Pine Capital first reported a position in TLSI in Q3 2025 and has held it in 4 quarters since. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • White Pine Capital held 547,577 shares of TriSalus Life Sciences worth $2.49M as of Q2 2026.
  • White Pine Capital bought 347,732 TriSalus Life Sciences shares in Q2 2026, an estimated $1.38M.
  • TriSalus Life Sciences made up 0.59% of White Pine Capital's portfolio in Q2 2026, its #48 holding.
  • White Pine Capital first reported a position in TriSalus Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on White Pine Capital's 13F filing for Q2 2026, filed 5 Aug 2026.